UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059603
Receipt number R000068168
Scientific Title Examining the Impact of Personal Relevance to Health on the Effectiveness of Motor-Function Feedback: A Randomized Controlled Trial Among Community-Dwelling Adults
Date of disclosure of the study information 2025/11/04
Last modified on 2025/10/31 14:34:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

How the Way of Communicating Motor Function Results Affects How People Perceive Health: A Study for Community Residents

Acronym

Motor Function Feedback Study

Scientific Title

Examining the Impact of Personal Relevance to Health on the Effectiveness of Motor-Function Feedback: A Randomized Controlled Trial Among Community-Dwelling Adults

Scientific Title:Acronym

PR, Feedback RCT

Region

Japan


Condition

Condition

No specific disease

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To empirically examine, among community-dwelling adults, whether the impact of differences in feedback content for motor function assessment-specifically, the presence versus absence of clinical implications on acceptance of the evaluation results and on personal relevance (PR) differs by PR level (high vs. low).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Perceived importance of the feedback results immediately after the motor function self-assessment.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Presenting the results of a motor function self-assessment with clinical implications regarding future care needs.

Interventions/Control_2

Presenting the results of a motor function self-assessment without clinical implications regarding future care needs.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Community-dwelling adults aged 60 years and older who are enrolled in the National Health Insurance or the Latter-Stage Elderly Health Insurance system, and are able to respond to web-based questionnaires using a smartphone or personal computer.

Key exclusion criteria

Individuals certified as Care Level 3-5 under Japan's Long-Term Care Insurance (LTCI) system.

Target sample size

240


Research contact person

Name of lead principal investigator

1st name Akihiro
Middle name
Last name Ozaka

Organization

Fukushima Medical University

Division name

Shirakawa Center for General Medicine

Zip code

961-0005

Address

2-1 Kamiyajiro, Toyochi, Shirakawa-shi, Fukushima, Japan

TEL

0248-22-2211

Email

z7ded76922644@gmail.com


Public contact

Name of contact person

1st name Sayaka
Middle name
Last name Nishioka

Organization

Kansai University

Division name

Graduate School of Psychology

Zip code

564-8680

Address

3-3-35 Yamate-cho, Suita-shi, Osaka, Japan

TEL

06-6368-1121

Homepage URL


Email

k579694@kansai-u.ac.jp


Sponsor or person

Institute

Shirakawa Kosei General Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency (JST)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shirakawa Kosei General Hospital

Address

2-1 Kamiyajiro, Toyochi, Shirakawa-shi, Fukushima 961-0005, Japan

Tel

0248-22-2211

Email

yamada-s@shirakawa-kosei.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 10 Month 14 Day

Date of IRB

2025 Year 10 Month 15 Day

Anticipated trial start date

2025 Year 11 Month 04 Day

Last follow-up date

2026 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 10 Month 31 Day

Last modified on

2025 Year 10 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068168